Rheumatic immune-related adverse events
Arthritis, myositis and other rheumatic side effects of checkpoint inhibitors.
Papers per year
Each bar is 12 months; the last one ends 17 Oct 2026. New trials in the same years: 2, 2, 1, 0, 4.
All papers from the last 12 months
160 papers (18 Oct 2025 – 17 Oct 2026), newest first. Loading the full list…
- Immune checkpoint inhibitor-induced myocarditis with myositis and/or myasthenia gravis overlap syndrome: A case seriesExp Ther Med2026 NovPMID 42840483
- A Case Series of Raynaud's Phenomenon in the Setting of Immune Checkpoint InhibitorsJ Immunother Precis Oncol2026 NovPMID 42799102
- Laboratory Medicine in Immune Checkpoint Inhibitor-Induced Autoimmune Disorders: Baseline Assessment, Diagnostic Algorithms, Monitoring, and Predictive BiomarkersAnn Lab Med2026 Nov 1PMID 42609092Review
- Profiling Immune-Related Adverse Events Associated with Imatinib: A Two-Decade Real-World Safety Study Based on FDA Adverse Event Reporting SystemCancer Invest2026 NovPMID 42402704
- A markedly increased CK-MB relative index suggests a skeletal muscle contribution to re-elevated troponin T in immune checkpoint inhibitor-associated myositisClin Chem Lab Med2026 Oct 26PMID 42453044
- Extracardiovascular immune-related adverse events in patients with suspected cardiac toxicity associated with immune checkpoint inhibitorsRev Med Interne2026 Oct 16PMID 42888061
- Immune checkpoint inhibitor-related myocarditis, myositis, and myasthenia gravis overlap syndrome: a single-center case series and systematic reviewSupport Care Cancer2026 Oct 15PMID 42878911Systematic reviewReview
- Pembrolizumab-Induced Sarcoidosis-Like Immune-Related Adverse Events: A Pooled Analysis of Published Cases and Report of a Novel Manifestation Involving Phosphocalcic MetabolismJ Immunother2026 Oct 14PMID 42886517
- [Myositis induced by immune checkpoint inhibitor therapy]Z Rheumatol2026 Oct 7PMID 42844401Review
- Immune-related colitis following head and neck reconstructive surgery in a patient receiving long-term nivolumabBMJ Case Rep2026 Oct 6PMID 42838709
More rheumatology trends
All specialties →CAR-T for autoimmune disease
CAR-T cell therapy for lupus, systemic sclerosis and myositis.
New lupus treatments
Anifrolumab, belimumab and other targeted drugs in systemic lupus.
Key point: Biologics have been increasingly incorporated into the treatment algorithm at earlier stages of SLE and are first-line treatments for certain manifestations such as lupus nephritis.
Ultrasound in rheumatology
Musculoskeletal and vascular ultrasound for diagnosis and monitoring.
Lung disease in systemic sclerosis
Interstitial lung disease in systemic sclerosis.
Giant cell arteritis and PMR
Giant cell arteritis, polymyalgia rheumatica and steroid-sparing treatment.
Key point: In PMR, interleukin-6 receptor blockers should be considered with glucocorticoids for relapsing disease and can be considered for new-onset high-risk patients.
Psoriatic arthritis
Psoriatic arthritis and its targeted treatments.
Too many papers to read?
PubDaily picks the ones that matter in your specialty and summarises them, about 10 minutes a week.
How these numbers are counted
PubMed query, searched in titles and abstracts by publication date:
("immune-related adverse event*"[tiab] OR irAE*[tiab]) AND (rheumat*[tiab] OR arthritis[tiab] OR myositis[tiab])Trials: ClinicalTrials.gov studies first submitted in each 12-month window that match the same terms. A query can miss synonyms or catch unrelated papers, so treat counts as approximate.